Literature DB >> 6961433

Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.

R M Huff, P B Molinoff.   

Abstract

The binding of [3H]domperidone and [3H]spiroperidol was examined in membranes prepared from rat striatum. Scatchard analysis of the binding of [3H]domperidone resulted in curvilinear plots consistent with the presence of multiple classes of binding sites. Nonlinear regression analysis of untransformed data showed that the curvature was best explained by the presence of two populations of binding sites. Scatchard plots of the binding of [3H]spiroperidol were linear, suggesting that this radioligand binds to a single class of receptors. However, results obtained in studies of the inhibition of [3H]spiroperidol binding by a number of competing ligands were not consistent with the interaction of these agents with a single class of binding sites. Computer-assisted analysis of the Hofstee plots of six competing ligands gave the same relative proportion for two classes of sites as determined by analysis of the binding of [3H]domperidone. The two classes of receptors labeled with [3H]spiroperidol had affinities for domperidone that were similar to those of the two populations of binding sites for [3H]domperidone. Furthermore, the number of binding sites for [3H]spiroperidol was equal to the total number of binding sites for [3H]domperidone. These findings suggest that the two radioligands bind to the same two classes of binding sites. It is unlikely that either of the two classes of striatal sites are receptors for serotonin. The approach described will make it possible to assess the effects of physiological or pharmacological manipulations on the densities or properties of subtypes of dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6961433      PMCID: PMC347380          DOI: 10.1073/pnas.79.23.7561

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor.

Authors:  M E Maguire; P M Van Arsdale; A G Gilman
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

2.  Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor.

Authors:  L T Williams; R J Lefkowitz
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

3.  Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-09       Impact factor: 4.436

Review 4.  Anti-schizophrenic drugs--membrane receptor sites of action.

Authors:  P Seeman
Journal:  Biochem Pharmacol       Date:  1977-10-01       Impact factor: 5.858

5.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

Authors:  J E Leysen; W Gommeren; P M Laduron
Journal:  Biochem Pharmacol       Date:  1978-02-01       Impact factor: 5.858

6.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

7.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon.

Authors:  M Rodbell; H M Krans; S L Pohl; L Birnbaumer
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

10.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

Authors:  P Seeman; M Chau-Wong; J Tedesco; K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  7 in total

1.  D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA.

Authors:  A Dearry; P Falardeau; C Shores; M G Caron
Journal:  Cell Mol Neurobiol       Date:  1991-10       Impact factor: 5.046

Review 2.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

3.  Domperidone as an unintended antipsychotic.

Authors:  Jack Ferrier
Journal:  Can Pharm J (Ott)       Date:  2014-03

4.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.

Authors:  F Karoum; M F Egan
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.

Authors:  D Grigoriadis; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

6.  Dopamine receptors in the developing sheep kidney.

Authors:  R A Felder; K T Nakamura; J E Robillard; M Kanadjian; P A Jose
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

7.  3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites.

Authors:  P Sokoloff; K Redouane; M Brann; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.